SEC Form 4 · accession 0001012975-15-000142

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Feb 19, 2015

Accepted (ET)

Feb 19, 2015 · 7:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001439222

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Feb 19, 2015	J	3,070,090	$0.00	D	0	I	See footnote
Common Stock^F4	Feb 19, 2015	J	760,195	$0.00	A	760,195	I	See footnote
Common Stock^F4	Feb 19, 2015	J	760,195	$0.00	D	0	I	See footnote
Common Stock	Feb 19, 2015	J	157,867	$0.00	A	184,386	D

No Table II lines on this filing.

F1Distribution of shares in kind by Third Rock Ventures, L.P. ("TRV") on a pro rata basis to its partners.
F2The shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC") and the Reporting Person is a Manager of TRV GP LLC, as such, each of TRV GP and TRV GP LLC and the Reporting Person exercises shared voting and investment power over the shares held of record by TRV. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
F3TRV GP received shares distributed in kind by TRV on a pro rata basis to its partners.
F4The shares are directly held by TRV GP. As such, each of TRV GP LLC and the Reporting Person exercises shared voting and investment power over the shares held of record by TRV GP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
F5Distribution of shares in kind by TRV GP on a pro rata basis to its partners.
F6The Reporting Person received shares distributed in kind by TRV GP on a pro rata basis to its partners.